The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000–2010

Osteoporosis International

Volumn 25, Issue 11, 2014, Pages 2555-2563

  Gibson Smith, D ^a,b   Klop, C ^a   Elders, P J M ^c   Welsing, P M J ^d   van Schoor, N ^e   Leufkens, H G M ^a   Harvey, N C ^f   van Staa, T P ^a   de Vries, F ^a,f,g,h  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Incidence; Osteoporosis; Osteoporotic fracture; Secular trends; Subsequent fracture

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; PARATHYROID HORMONE; STRONTIUM RANELATE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; FOREARM FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; RISK FACTOR; SECONDARY OSTEOPOROSIS; SPINE FRACTURE; UNITED KINGDOM; AGE DISTRIBUTION; COMORBIDITY; HIP FRACTURES; INCIDENCE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PROCEDURES; RECURRENT DISEASE; RISK ASSESSMENT; SEX RATIO; VERY ELDERLY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; GREAT BRITAIN; HIP FRACTURES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION;

EID: 84919841447     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-014-2799-x     Document Type: Article

References (39)

1. Lee YK, Lee YJ, Ha YC, Koo KH (2014) Five-year relative survival of patients with osteoporotic hip fracture. J Clin Endocrinol Metab 99:97–100
2. Bertran M, Norman R, Kemp L, Vos T (2011) Review of the long-term disability associated with hip fractures. Inj Prev 17:365–370
3. Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977–2001. J Bone Miner Res 24:1299–1307
4. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721–739
5. Warriner AH, Patkar NM, Yun H, Delzell E (2012) Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Curr Osteoporos Rep 10:22–27
6. Huntjens KM, Kosar S, van Geel TA, Geusens PP, Willems P, Kessels A, Brink P, van Helden S (2010) Risk of subsequent fracture and mortality within 5 years after a non-vertebral fracture. Osteoporos Int 21:2075–2082
7. Johnell O, Kanis JA, Odén A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jönsson B (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int 15:175–179
8. van Helden S, Cals J, Kessels F, Brink P, Dinant GJ, Geusens P (2006) Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int 17:348–354
9. von Friesendorff M, Besjakov J, Akesson K (2008) Long-term survival and fracture risk after hip fracture: a 22-year follow-up in women. J Bone Miner Res 23:1832–1841
10. van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ (2009) Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 68:99–102
11. Sawalha S, Parker MJ (2012) Characteristics and outcome in patients sustaining a second contralateral fracture of the hip. J Bone Joint Surg (Br) 94:102–106
12. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521
13. Pearse EO, Redfern DJ, Sinha M, Edge AJ (2003) Outcome following a second hip fracture. Injury 34:518–521
14. Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, Melton LJ, Cummings SR, Kanis JA (2011) Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 22:1277–1288
15. Alves SM, Economou T, Oliveira C, Ribeiro AL, Neves N, Gomez-Barrena E, Pina MF (2013) Osteoporotic hip fractures: bisphosphonates sales and observed turning point in trend. A population based retrospective study. Bone 53:430–436
16. Turkington P, Madonald S, Elliott J, Beringer T (2012) Hip fracture in Northern Ireland, 1985–2010. Are age specific rates still rising? Ulster Med J 81:123–126
17. Melton LJ III, Therneau TM, Larson DR (1998) Long-term trends in hip fracture prevalence: the influence of hip fracture incidence and survival. Osteoporos Int 8:68–74
18. National Institute for Clinical Excellence (2005) Technology appraisal guidance 87 bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
19. Omsland TK, Holvik K, Meyer HE, Center JR, Emaus N, Tell GS, Schei B, Tverdal A, Gjesdal CG, Grimnes G, Forsmo S, Eisman JA, Søgaard AJ (2012) Hip fractures in Norway 1999–2008: time trends in total incidence and second hip fracture rates: a NOREPOS study. Eur J Epidemiol 27:807–814
20. Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL (2009) Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20:687–694
21. Kanis JA, Mc Closkey EV, Johansson H, Oden A, Ström O, Borgström F (2010) Development and use of FRAX in osteoporosis. Osteoporos Int 21:407–413
22. Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG (2000) The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359–366
23. Warriner A, Patkar N, Curtis J, Delzell E, Gary L, Kilgore M, Saag K (2011) Which fractures are most attributable to osteoporosis? J Clin Epidemiol 64:46–53
24. Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 6:59–155
25. Egan M, Jaglal S, Byrne K, Wells J, Stolee P (2008) Factors associated with a second hip fracture: a systematic review. Clin Rehabil 22:272–282
26. Colón-Emeric CS, Lyles KW, Su G, Pieper CF, Magaziner JS, Adachi JD, Bucci-Rechtweg CM, Haentjens P, Boonen S (2011) Clinical risk factors for recurrent fracture after hip fracture: a prospective study. Calcif Tissue Int 88:425–431
27. Reid DM, Harvie J (1997) Secondary osteoporosis. Baillieres Clin Endocrinol Metab 11:83–91
28. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952–1960
29. Carbone LD, Johnson KC, Robbins J, Larson JC, Curb JD, Watson K, Gass M, Lacroix AZ (2010) Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI). J Bone Miner Res 25:873–881
30. Doggrell SA (2003) Present and future pharmocatherapy for osteoporosis. Drugs Today 39:633
31. Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14–21
32. Budicǎ CR, Cristea ŞT, Panait GH (2010) Risk assessment of new fracture following fragility hip fracture. Arch Balk Med Union 45:40–48
33. Curtis JR, Arora T, Matthews RS, Taylor A, Becker DJ, Colon-Emeric C, Kilgore ML, Morrisey MA, Saag KG, Safford MM, Warriner A, Delzell E (2010) Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death. J Am Med Dir Assoc 11:584–591
34. Chen JS, Sambrook PN, Simpson JM, Cameron ID, Cumming RG, Seibel MJ et al (2009) Risk factors for hip fracture among institutionalised older people. Age Ageing 38:429–434
35. Thomas SL, Edwards CJ, Smeeth L, Cooper C, Hall AJ (2008) How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? Arthritis 59:1314–1321
36. Smith P, Ariti C, Bardsley M (2013) Focus on hip fracture: trends in emergency admission for fractured neck of femur, 2001 to 2011. Nuffield Trust/Health Foundation
37. The American Society for Bone and Mineral Research (2013) Annual meeting. http://www.asbmr.org/asbmr-2013-abstract-detail?aid=ff336fa6-534a-4a7b-b96a-63ee30d19fcb. Accessed 08 Jan 2014
38. Watson J, Wise L, Green J (2007) Prescribing hormone therapy for menopause, tibolone and bisphosphonates in women in the UK between 1991 and 2005. Eur J Clin Pharmacol 63:843–849
39. Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35:319–326